Form 4: Hippo Holdings CFO Stewart Ellis Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Hippo Holdings CFO Stewart Ellis executed sales of common stock on January 2, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On January 2, 2025, Stewart Ellis, CFO/Chief Strategy Officer of Hippo Holdings Inc., sold shares of common stock.
- The sales were executed under a Rule 10b5-1 trading plan established on September 10, 2024.
- A total of 5,667 shares were sold at a weighted average price of $26.1116, and 4,333 shares were sold at a weighted average price of $26.6423.
- Following the transactions, Ellis directly owns 318,215 shares of common stock, which includes 120,525 RSUs, and indirectly owns 10,335 shares through Preservation Trust Company, Inc., Trustee of the Desertfish Nevada Trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating routine transactions. The sentiment is neutral as it simply reports the sale of shares under a pre-arranged trading plan.
Industry Context
Executive share sales are a common occurrence and are often pre-planned using Rule 10b5-1 trading plans to avoid accusations of insider trading. The market typically analyzes these sales in the context of the executive's overall holdings and the company's performance.
Comparison to Industry Standards
- Executive compensation and trading activities are closely monitored across the insurance and fintech industries.
- Companies like Lemonade, Root, and SelectQuote are often compared to Hippo in terms of executive compensation structures and insider trading activities.
- Benchmarking against these companies involves analyzing the frequency and size of insider transactions, as well as the use of Rule 10b5-1 plans.
Stakeholder Impact
- The sale of shares by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
- The impact on employees, customers, suppliers, and creditors is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2024-09-10 | Date of Rule 10b5-1 trading plan. |
| 2025-01-02 | Date of transaction (sale of shares). |
| 2025-01-03 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.